Active Ingredient: Semaglutide (GLP-1 receptor agonist)
Dosage: 0.5 mg, administered once a week
Administration: Subcutaneous injection in the abdomen, thigh, or upper arm
Weight Management: Supports gradual and sustainable weight loss
Blood Sugar Control: Lowers blood glucose and HbA1c levels
Cardiovascular Protection: Reduces risk of heart attack, stroke, and cardiovascular death in high-risk patients
Ozempic® 0.5mg (Japanese version) is an advanced injectable medication designed to improve glycemic control in adults with type 2 diabetes. Powered by semaglutide, it works by stimulating insulin secretion, reducing glucagon levels, and slowing gastric emptying.
In addition to blood sugar management, Ozempic® has been clinically proven to promote weight loss and protect against major cardiovascular events in patients with existing heart disease.
Ingredients
Semaglutide – active ingredient
Dibasic sodium phosphate dihydrate – stabilizer
Phenol – preservative
Propylene glycol – solvent
Water for injections – solvent
How to Use
Starting Dose: 0.25 mg once weekly for the first 4 weeks
Increase to: 0.5 mg after 4 weeks
Administration Sites: Abdomen, thigh, or upper arm – rotate sites to prevent irritation
Missed Dose: Take within 5 days; otherwise, skip and continue with the regular schedule
Can be injected with or without food, at any time of day
Extra Info
Common Side Effects: Nausea, vomiting, diarrhea, abdominal discomfort, decreased appetite
Serious Side Effects: Pancreatitis, thyroid tumors (including MTC), kidney injury
Storage: Refrigerate between 2–8°C before first use; after first use, store at room temperature for up to 6 weeks
What’s in the Box
1 pre-filled pen containing Ozempic® 0.5 mg (Japanese packaging)
Pen needles (may vary by distributor)
Patient information leaflet and instructions
Why Choose
Ozempic® 0.5mg is trusted worldwide for its dual benefits – controlling blood sugar and supporting weight loss – with proven cardiovascular protection. Manufactured by Novo Nordisk, a global leader in diabetes care, it offers a convenient once-weekly regimen with lasting results.
For patients focusing primarily on weight reduction without diabetes treatment, you may also consider Saxenda® (Liraglutide) Weight Loss Injection, another GLP-1 based therapy.
